Waldencast

Founder and CEO Michel Brousset leads acquisition strategy, drawing on his background as a senior executive at L'Oréal's Professional Products Division. Chairman Felipe Dutra, the former CFO of Anheuser-Busch InBev, brings public-market and M&A discipline to capital allocation. The board, which includes executives with experience at Unilever and Shiseido, reviews all major transactions.

Waldencast is a publicly traded operating company, not a closed-end fund. It acquires majority stakes with no predetermined exit timeline — founders retain meaningful equity and operational control. The Nasdaq listing (ticker: WALD) provides permanent capital, meaning the firm can hold assets indefinitely rather than being forced to sell within a fund's 7–10 year lifecycle, a structure that mirrors the patience of a family office.

The firm targets purpose-driven beauty, personal care, and wellness brands typically generating between $50 million and $200 million in annual revenue. Target brands must have strong founder-led cultures, demonstrable consumer loyalty, and scalable distribution models. Waldencast has stated it looks for brands with category-defining potential and mission-oriented positioning rather than commodity personal-care products.

Waldencast exclusively makes direct majority acquisitions — it does not operate as a fund-of-funds or participate in limited-partner commitments. The firm raises and deploys permanent capital through its Nasdaq-listed vehicle, meaning each acquisition is consolidated into the public company's financials and becomes an operating subsidiary.

Waldencast has publicly stated it focuses exclusively on beauty, personal care, and wellness, avoiding categories such as household products, over-the-counter pharmaceuticals, and foods. Within beauty, the firm has not disclosed any formal avoidance criteria, though its active portfolio is concentrated in prestige, clinical, and direct-to-consumer channels rather than mass-market or commodity segments.

As a publicly traded vehicle, Waldencast typically acquires brands outright by purchasing majority equity stakes and does not solicit co-investors on a deal-by-deal basis. The firm's permanent-capital structure allows it to raise additional equity through public markets or debt facilities to fund acquisitions, avoiding the complexity of assembling ad-hoc co-investment syndicates for each transaction.

Waldencast completed a business combination with Obagi Global Holdings and Milk Makeup in July 2022, a transaction that also resulted in the firm's listing on Nasdaq. Obagi was acquired from a consortium led by Haitong International, while Milk Makeup was a direct acquisition of the original founder-backed company. The deal was structured as a reverse merger into a SPAC sponsored by Waldencast itself, a mechanism that gave both brands immediate public-market liquidity alongside permanent operational capital.